Management of Typhoid Fever – Clinical and Historical Perspectives in Korea
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Typhoid fever, showed a dramatic decrease in its incidence from 56 per 100,000 population just after Korea's independence to <1 per 100,000 population in 2000s. The clinical features of patients with typhoid fever in Korea were not too different from those reported in textbooks. Beyond cultures and Widal test, other diagnostic techniques such as string capsule culture and polymerase chain reaction have been tried in Korea. As chloramphenicol is not used anymore in Korea, ampicillin, cotrimoxazole, fluoroquinolones, and third-generation cephalosporins have been administered for therapy of typhoid fever. Especially, ciprofloxacin and ceftriaxone were successfully tried with shorter duration of treatment (1 week). However, cases of treatment failure and resistance in ciprofloxacin were reported in Korea, which requires a great caution. As preventive vaccines, parenteral Vi polysaccharide vaccine and oral live attenuated vaccine are mainly used in Korea. The decline in the number of chronic carriers of typhoid fever in Korea by the roles of doctors and patient management from the health care authorities such as Korea Centers for Diseases Control and Prevention, prescription of effective antimicrobial agents, and increased piped water supply ratio are considered to be the major contributing factors to the reduction in the outbreak of typhoid fever in Korea.
Abstract
Typhoid fever, showed a dramatic decrease in its incidence from 56 per 100,000 population just after Korea's independence to <1 per 100,000 population in 2000s. The clinical features of patients with typhoid fever in Korea were not too different from those reported in textbooks. Beyond cultures and Widal test, other diagnostic techniques such as string capsule culture and polymerase chain reaction have been tried in Korea. As chloramphenicol is not used anymore in Korea, ampicillin, cotrimoxazole, fluoroquinolones, and third-generation cephalosporins have been administered for therapy of typhoid fever. Especially, ciprofloxacin and ceftriaxone were successfully tried with shorter duration of treatment (1 week). However, cases of treatment failure and resistance in ciprofloxacin were reported in Korea, which requires a great caution. As preventive vaccines, parenteral Vi polysaccharide vaccine and oral live attenuated vaccine are mainly used in Korea. The decline in the number of chronic carriers of typhoid fever in Korea by the roles of doctors and patient management from the health care authorities such as Korea Centers for Diseases Control and Prevention, prescription of effective antimicrobial agents, and increased piped water supply ratio are considered to be the major contributing factors to the reduction in the outbreak of typhoid fever in Korea.
참고문헌 (18)
- The Korean Society of Infectious Diseases, "Japanese colonial era - Typhoid Fever", pp.434~437 (2009), Koonja
- 2016 infectious diseases surveillance yearbook, "Korea Centers for Disease Control and Prevention (KCDC)", KCDC, ~ (2017)
- Korea Centers for Disease Control and Prevention (KCDC), "Guidelines for infectious disease control operation", KCDC, ~ (2011)
- Kim YG, "A study on the status of reporting typhoid fever cases admitted", Korean J Epidemiol, 7, pp.240~252 (1985)
- Chun CH, "Brief history of infectious diseases in Korea", Korean J Infect Dis, 1, pp.72~78 (1969)
- Chung HY, "Enteric bacterial infection", Korean J Infect Dis, 1, pp.19~26 (1969)
- Kim WJ, "Typhoid fever", J Korean Med Assoc, 35, pp.863~869 (1992)
- Kim JP, "Management of ileal perforation due to typhoid fever", Ann Surg, 181, pp.88~91 (1975)
- Song JH, "Development of a novel diagnostic method of typhoid fever using polymerase chain reaction", Korean J Med, 46, pp.229~237 (1994)
- Oh IH, "Treatment of typhoid fever", Korean J Infect Dis, 1, pp.14~18 (1969)
- 김윤정, "국내 항균제의 사용 실태와 변화 추세(V)", Infection and Chemotherapy, 44(6), pp.411~418 (2012), 대한감염학회
- Choe KW, "Ciprofloxacin therapy in typhoid fever", J Korean Soc Chemother, 8, pp.105~110 (1990)
- 김대범, "시프로프록사신에 반응하지 않은 해외유입 장티푸스 3예", 대한내과학회지, 77(3), pp.377~381 (2009), 대한내과학회
- Woo J, "Typhoid fever, cholera vaccine", Korean J Med, 51(Suppl 2), pp.77~82 (1996)
- Hwang C, "The amendment tendency analysis of the Korean infectious disease prevention act and a recommendation for the next amendment", pp.1998
- 천병철, "우리나라 감염병관련 법률 및 정책의 변천과 전망", Infection and Chemotherapy, 43(6), pp.474~484 (2011), 대한감염학회
- Establishment of strategies improving the efficiency of typhoid carriers search operation, "Inha University College of Medicine", ~ (2008)
- "2015 water supply statistics"[URL]